Teal concentric circle design with Nashville city image in a round frame with dots around the image.

Thursday−Friday, May 28–29|Nashville, TN

Pri-Med Nashville | Regional CME/CE Conference

Andrew E. Budson, MD
Amy Clouse, MD, FAAFP
Lisa M. Ferreira, MD, FOMA
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Jonette Keri, MD, PhD
Pamela Kushner, MD, FAAFP
Vani Potluri, MD, DABOM
Shirah Vollmer, MD

Learn More

Thursday, May 28 8:15–9am

Beyond SSRIs: Treating Complicated Depression

Karol E. Watson, MD, PhD

Disclosures

The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.

Financial Disclosures

Samuel Belok, MD
Information to come
Andrew E. Budson, MD
Advisor: AbbVie; Speaker: Eli Lilly; Researcher: Vox Neuro, Eisai
Amy Clouse, MD, FAAFP
Stock Holder (publicly traded company): Eli Lilly and Novo Nordisk Inc.
Lisa M. Ferreira, MD, FOMA
Information to come
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Consultant: OptumRx
Jennifer B. Green, MD
Consultant: Anji, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Merck, Novo Nordisk, Valo, Vertex, Vertex; Researcher: Bluedrop, Boehringer Ingelheim, Merck, Roche
Jonette Keri, MD, PhD
Advisor: Almirall; Advisor: Sanofi
Pamela Kushner, MD, FAAFP
Advisor: GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novo Nordisk, Lilly, Bausch/SALIX, Haleon, Verdiva, Abbott, Corcept, and Bayer; Speaker: GlaxoSmithKline, Boehringer Ingelheim, Phathom, AstraZeneca, Novo Nordisk, Lilly, Janssen, Haleon, Corcept, and Lilly
Peter Lin, MD, CCFP
Speaker: Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eisai, Eli Lilly, GlaxoSmithKline, Medtronic, Merck, Moderna, Novo Nordisk, Pfizer, Sanofi
Vani Potluri, MD, DABOM
No relevant financial relationships disclosed.
Charles Vega, MD, FAAFP
Consultant: GlaxoSmithKline, Boehringer Ingelheim, Exact Sciences
Shirah Vollmer, MD
No relevant financial relationships disclosed.
Karol E. Watson, MD, PhD
Consultant: Boehringer Ingelheim, Eli Lilly, Merck, Novartis, Regeneron

Other Disclosures

All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.